Clinical trial
Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed…
NCT00357552 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other · Completed
Key facts
| NCT number | NCT00357552 |
|---|---|
| Title | Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy |
| Official title | A Pilot Study of Lopinavir/Ritonavir in Participants Experiencing Virologic Relapse on NNRTI-Containing Regimens |
| Lead sponsor | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Emtricitabine/Tenofovir disoproxil fumarate, Lopinavir/Ritonavir |
| Enrollment | 123 |
| Start date | Jan 1, 2008 |
| Primary completion | Oct 1, 2010 |
| Completion | May 1, 2012 |
| First posted | Jul 27, 2006 |
| Last update posted | Mar 20, 2018 |
| Countries | India, Malawi, South Africa, Tanzania, Thailand |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: